Nasdaq Trims Gains as Markets Await Anthropic Trading Debut

U.S. stocks pulled back on Thursday as the Nasdaq Composite gave up an early rally, extending a period of selling pressure on Wall Street. The index, which had climbed as much as 2.1% earlier in the session, ended the day little changed. The Dow Jones Industrial Average fell 492 points, or 1%, while the S&P 500 declined 0.5%.
Market movement was centered on the anticipated stock market debut of artificial intelligence company Anthropic. Shares were priced at $83 on Wednesday, exceeding an initial expected range of $70 to $78. The offering, which values the firm at approximately $1.5 trillion, saw the company and its seven co-founders sell roughly 980 million shares to raise $81.3 billion. This figure surpasses the $75 billion IPO record previously held by SpaceX, which debuted in June. Co-founders Dario and Daniela Amodei marked the occasion by ringing the Nasdaq opening bell on Thursday.
Investors are closely monitoring the debut of the Claude AI developer as a potential indicator for the broader sector. “It’ll be an important barometer for investors’ AI appetite,” said Callie Cox, director of investment strategy at Plancorp. “Wall Street needs a sign that investors still believe in the potential for AI beyond already-elevated expectations.”

Financial interest in the IPO had initially buoyed shares with ties to Anthropic, including Amazon, Alphabet, and Broadcom, all of which posted gains in premarket trading before the broader market reversed. However, the technology sector remained under pressure. Advanced Micro Devices shares dropped more than 10% following a disclosure by Hunterbrook of a short position in the company, which raised concerns regarding potential U.S. export restrictions involving China. Nvidia shares declined nearly 1%, while Micron Technology saw an increase of more than 1%.
Broad market losses were not limited to technology. Major Dow components Goldman Sachs and Caterpillar faced significant declines, falling more than 5% and 8% respectively for the week. In the healthcare sector, Johnson & Johnson and Merck dropped nearly 3% and 4%.
Market sentiment has faced ongoing challenges from volatility in the AI space, alongside concerns regarding the capital expenditures required for data center infrastructure. The Nasdaq entered correction territory two weeks ago, defined by a 10% decline from its peak in early October, as investors weigh whether interest in artificial intelligence can persist amidst the current market climate.